Literature DB >> 15942329

Dementia update 2005.

John C Morris1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15942329     DOI： 10.1097/01.wad.0000167923.56275.d8

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN： 0893-0341            Impact factor:   2.703


× No keyword cloud information.
  13 in total

1.  Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?

Authors:  Nikolaos Scarmeas
Journal:  Am J Epidemiol       Date:  2007-02-13       Impact factor: 4.897

2.  Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study.

Authors:  Hyun Cho; Dong Won Yang; Young Min Shon; Beum Saeng Kim; Yeong In Kim; Young Bin Choi; Kwang Soo Lee; Yong Soo Shim; Bora Yoon; Woojin Kim; Kook Jin Ahn
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

3.  The utility of the Dementia Severity Rating Scale in differentiating mild cognitive impairment and Alzheimer disease from controls.

Authors:  Joel C Mitchell; Malcolm B Dick; Amanda E Wood; Andre M Tapp; Raphael Ziegler
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jul-Sep       Impact factor: 2.703

4.  How could disclosing incidental information from whole-genome sequencing affect patient behavior?

Authors:  Kurt D Christensen; Robert C Green
Journal:  Per Med       Date:  2013-06       Impact factor: 2.512

5.  Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directions.

Authors:  J Scott Roberts; Sarah M Tersegno
Journal:  Future Neurol       Date:  2010-07-01

Review 6.  Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics.

Authors:  J S Roberts; K D Christensen; R C Green
Journal:  Clin Genet       Date:  2011-07-18       Impact factor: 4.438

Review 7.  Children of persons with Alzheimer disease: what does the future hold?

Authors:  Lissy Jarvik; Asenath LaRue; Deborah Blacker; Margaret Gatz; Claudia Kawas; John J McArdle; John C Morris; James A Mortimer; John M Ringman; Linda Ercoli; Nelson Freimer; Izabella Gokhman; Jennifer J Manly; Brenda L Plassman; Natalie Rasgon; Jeffrey Scott Roberts; Trey Sunderland; Gary E Swan; Phillip A Wolf; Alan B Zonderman
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jan-Mar       Impact factor: 2.703

8.  Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.

Authors:  Kurt D Christensen; J Scott Roberts; Peter J Whitehouse; Charmaine D M Royal; Thomas O Obisesan; L Adrienne Cupples; Jacqueline A Vernarelli; Deepak L Bhatt; Erin Linnenbringer; Melissa B Butson; Grace-Ann Fasaye; Wendy R Uhlmann; Susan Hiraki; Na Wang; Robert Cook-Deegan; Robert C Green
Journal:  Ann Intern Med       Date:  2016-01-26       Impact factor: 25.391

9.  Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk.

Authors:  Kurt D Christensen; J Scott Roberts; Wendy R Uhlmann; Robert C Green
Journal:  Genet Med       Date:  2011-05       Impact factor: 8.822

10.  Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.

Authors:  Kurt D Christensen; J Scott Roberts; Charmaine D M Royal; Grace-Ann Fasaye; Thomas Obisesan; L Adrienne Cupples; Peter J Whitehouse; Melissa Barber Butson; Erin Linnenbringer; Norman R Relkin; Lindsay Farrer; Robert Cook-Deegan; Robert C Green
Journal:  Genet Med       Date:  2008-03       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.